Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA
Heimer R, Barbour R, Palacios WR, Nichols LG, Grau LE. Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA. AIDS And Behavior 2013, 18: 452-463. PMID: 23921583, PMCID: PMC3917972, DOI: 10.1007/s10461-013-0572-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultConnecticutDrug UsersFemaleHarm ReductionHealth Services AccessibilityHumansInterviews as TopicLongitudinal StudiesMaleNeedle SharingPrevalenceResidence CharacteristicsRisk FactorsSocial EnvironmentSocioeconomic FactorsSubstance Abuse, IntravenousSubstance-Related DisordersSuburban Health ServicesSuburban PopulationYoung AdultConceptsHarm reduction servicesInjection riskReduction servicesAbuse treatmentInjection drug useInjection drug usersRisky injection practicesPoor social supportDisadvantaged census tractsSubstance abuse treatmentDrug abuse treatmentPatterns of heroinRespondent-driven samplingHepatitis BInfluence of residenceSevere depressionOpioid overdosesSerological testingOverdose deathsGeneral populationInjection practicesDrug usersDrug useYounger ageRisk behaviorsIndividual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study
Eritsyan K, Heimer R, Barbour R, Odinokova V, White E, Rusakova MM, Smolskaya TT, Levina OS. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open 2013, 3: e002645. PMID: 23794559, PMCID: PMC3686233, DOI: 10.1136/bmjopen-2013-002645.Peer-Reviewed Original ResearchHIV prevalenceActive IDUsHepatitis C virus infectionC virus infectionCross-sectional studyTarget sample sizeHarm reduction programsCross-sectional surveyRespondent-driven samplingHepatitis CPrevalent infectionHIV knowledgeHIV epidemicSerological testingVirus infectionDrug treatmentInjection riskHIVEnzyme immunoassayNetwork-level variablesPrevalenceSexual behaviorIDUsProtective behaviorsHierarchical regression models